Regend Therapeutics
Clinical trials sponsored by Regend Therapeutics, explained in plain language.
-
Kidney repair cells enter first human safety trial for diabetic kidney disease
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called REGEND003 in 15 people with type 2 diabetes and chronic kidney disease. The treatment uses special kidney cells that may help repair kidney damage. The main goal is to check if the therapy is safe and tolerable, not yet …
Phase: PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Could stem cells repair damaged lungs in COPD?
Disease control Recruiting nowThis early-stage study tests a new cell therapy called REGEND007 for people with chronic obstructive pulmonary disease (COPD). The treatment uses special airway stem cells given through an IV to try to repair lung tissue. The study will include 12 adults aged 40-80 and will focus…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Stem cells aim to repair damaged airways in kids with rare lung condition
Disease control Recruiting nowThis early-phase study tests whether airway basal stem cells can safely help children with bronchiolitis obliterans, a chronic lung disease that narrows the airways. The trial will enroll 12 children aged 28 days to 18 years who have severe breathing problems. Researchers will mo…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:47 UTC